{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:29:04Z","timestamp":1768980544788,"version":"3.49.0"},"reference-count":107,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Randomized control trials show beneficial effects of heparin in high-risk pregnancies to prevent preeclampsia and intrauterine growth restriction. However, the lack of placental pathology data in these trials challenges the assumption that heparin is a placental anticoagulant. Recent data show that placental infarction is probably associated with abnormalities in development of the placenta, characterized by poor maternal perfusion and an abnormal villous trophoblast compartment in contact with maternal blood, than with maternal thrombophilia. At-risk pregnancies may therefore be predicted by noninvasive prenatal testing of placental function in mid-pregnancy. Heparin has diverse cellular functions that include direct actions on the trophoblast. Dissecting the non\u2013anticoagulant actions of heparin may indicate novel and safer therapeutic targets to prevent the major placental complications of pregnancy.<\/jats:p>","DOI":"10.1182\/blood-2011-07-319749","type":"journal-article","created":{"date-parts":[[2011,8,26]],"date-time":"2011-08-26T03:07:34Z","timestamp":1314328054000},"page":"4780-4788","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":49,"title":["Is heparin a placental anticoagulant in high-risk pregnancies?"],"prefix":"10.1182","volume":"118","author":[{"given":"John C. P.","family":"Kingdom","sequence":"first","affiliation":[{"name":"Maternal-Fetal Medicine Division, Department of Obstetrics & Gynecology; and"},{"name":"Program in Development and Fetal Health, Samuel Lunenfeld Research Institute at Mount Sinai Hospital, University of Toronto, Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Drewlo","sequence":"additional","affiliation":[{"name":"Program in Development and Fetal Health, Samuel Lunenfeld Research Institute at Mount Sinai Hospital, University of Toronto, Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"9","key":"2019111807070775800_B1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.amjcard.2009.06.040","article-title":"Use of low molecular weight heparin in pregnant women with mechanical heart valves.","volume":"104","author":"Yinon","year":"2009","journal-title":"Am J Cardiol"},{"key":"2019111807070775800_B2","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition).","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"issue":"5","key":"2019111807070775800_B3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1182\/blood.V36.5.623.623","article-title":"Fetal effects of Coumadin administered during pregnancy.","volume":"36","author":"Hirsh","year":"1970","journal-title":"Blood"},{"issue":"1","key":"2019111807070775800_B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203309353171","article-title":"Review: low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity?","volume":"19","author":"Lefkou","year":"2010","journal-title":"Lupus"},{"issue":"6","key":"2019111807070775800_B5","first-page":"844","article-title":"Anticoagulant therapy of patients with repeated placental infarction.","volume":"43","author":"Buyse","year":"1974","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2019111807070775800_B6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humupd\/dmn031","article-title":"The potential role of heparin in assisted conception.","volume":"14","author":"Nelson","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"7","key":"2019111807070775800_B7","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/humrep\/dep086","article-title":"Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial.","volume":"24","author":"Urman","year":"2009","journal-title":"Hum Reprod"},{"issue":"7076","key":"2019111807070775800_B8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"issue":"10","key":"2019111807070775800_B9","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111807070775800_B10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/00016340903294272","article-title":"Does low molecular weight heparin shorten term labor?","volume":"89","author":"Ekman-Ordeberg","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3-4","key":"2019111807070775800_B11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000175157","article-title":"Nonanticoagulant heparins and inhibition of cancer.","volume":"36","author":"Casu","year":"2008","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"2","key":"2019111807070775800_B12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"issue":"21","key":"2019111807070775800_B13","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"issue":"17","key":"2019111807070775800_B14","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"issue":"18","key":"2019111807070775800_B15","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMcp1005330","article-title":"Clinical practice. Recurrent miscarriage.","volume":"363","author":"Branch","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111807070775800_B16","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/path.1926","article-title":"Early embryonic demise: no evidence of abnormal spiral artery transformation or trophoblast invasion.","volume":"208","author":"Ball","year":"2006","journal-title":"J Pathol"},{"issue":"6","key":"2019111807070775800_B17","first-page":"CD006780","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.","author":"Dodd","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2019111807070775800_B18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1538-7836.2008.03230.x","article-title":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial.","volume":"7","author":"Rey","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111807070775800_B19","first-page":"771","article-title":"Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial.","volume":"104","author":"Gris","year":"2010","journal-title":"Thromb Haemost"},{"issue":"8","key":"2019111807070775800_B20","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3109\/14767058.2010.545911","article-title":"Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications.","volume":"24","author":"Kupferminc","year":"2011","journal-title":"J Matern Fetal Neonat Med"},{"issue":"2","key":"2019111807070775800_B21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MBC.0b013e328343315c","article-title":"Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.","volume":"22","author":"Kupferminc","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2019111807070775800_B22","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1053\/plac.2002.0932","article-title":"The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus\u2013a review.","volume":"24","author":"Jauniaux","year":"2003","journal-title":"Placenta"},{"issue":"6","key":"2019111807070775800_B23","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1210\/jcem.87.6.8563","article-title":"Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy.","volume":"87","author":"Burton","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019111807070775800_B24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0002-9378(99)70518-1","article-title":"Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited.","volume":"181","author":"Burton","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2019111807070775800_B25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-0030-1270344","article-title":"Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia.","volume":"37","author":"Lockwood","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"6595","key":"2019111807070775800_B26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/383073a0","article-title":"Role of tissue factor in embryonic blood vessel development.","volume":"383","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"issue":"3","key":"2019111807070775800_B27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm825","article-title":"The thrombomodulin-protein C system is essential for the maintenance of pregnancy.","volume":"9","author":"Isermann","year":"2003","journal-title":"Nat Med"},{"issue":"5","key":"2019111807070775800_B28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1067\/mob.2002.126866","article-title":"Punch biopsy of the human placental bed.","volume":"187","author":"Robson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2019111807070775800_B29","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1172\/JCI119387","article-title":"Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?","volume":"99","author":"Zhou","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111807070775800_B30","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/HYPERTENSIONAHA.107.102905","article-title":"Trophoblasts reduce the vascular smooth muscle cell proatherogenic response.","volume":"51","author":"Hering","year":"2008","journal-title":"Hypertension"},{"issue":"6","key":"2019111807070775800_B31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy.","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"issue":"2","key":"2019111807070775800_B32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: a question of attribution.","volume":"143","author":"Bagot","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111807070775800_B33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1521-6934(03)00019-1","article-title":"Haemostasis in normal and abnormal pregnancy.","volume":"17","author":"O'Riordan","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"2019111807070775800_B34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejogrb.2004.06.038","article-title":"Changes in haemostasis during normal pregnancy.","volume":"119","author":"Uchikova","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2019111807070775800_B35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bpobgyn.2009.11.010","article-title":"Coagulation in pregnancy.","volume":"24","author":"Thornton","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"9403","key":"2019111807070775800_B36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(03)15309-3","article-title":"Coagulation, inflammation, and pregnancy complications.","volume":"363","author":"Sarig","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"2019111807070775800_B37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0300-2977(94)00104-H","article-title":"Haematological and biochemical profile of uncomplicated pregnancy in nulliparous women; a longitudinal study.","volume":"46","author":"van Buul","year":"1995","journal-title":"Neth J Med"},{"issue":"4 Pt 2","key":"2019111807070775800_B38","first-page":"H1060","article-title":"Serial study of factors influencing changes in cardiac output during human pregnancy.","volume":"256","author":"Robson","year":"1989","journal-title":"Am J Physiol"},{"issue":"1","key":"2019111807070775800_B39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1160\/TH10-06-0399","article-title":"Increased risk of gestational vascular complications in women with low free tissue factor pathway inhibitor plasma levels out of pregnancy.","volume":"105","author":"Ittel","year":"2011","journal-title":"Thromb Haemost"},{"issue":"12","key":"2019111807070775800_B40","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1242\/dev.020099","article-title":"Early patterning of the chorion leads to the trilaminar trophoblast cell structure in the placental labyrinth.","volume":"135","author":"Simmons","year":"2008","journal-title":"Development"},{"issue":"8","key":"2019111807070775800_B41","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0143-4004(05)80185-7","article-title":"Quantitative evidence for the spatial dispersal of trophoblast nuclei in human placental villi during gestation.","volume":"15","author":"Mayhew","year":"1994","journal-title":"Placenta"},{"issue":"4","key":"2019111807070775800_B42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.placenta.2009.01.002","article-title":"Evidence for transcriptional activity in the syncytiotrophoblast of the human placenta.","volume":"30","author":"Ellery","year":"2009","journal-title":"Placenta"},{"issue":"1","key":"2019111807070775800_B43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ajog.2005.07.039","article-title":"Apoptosis and its role in the trophoblast.","volume":"195","author":"Huppertz","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2019111807070775800_B44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/cdd.2009.1","article-title":"Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast.","volume":"16","author":"Baczyk","year":"2009","journal-title":"Cell Death Differ"},{"issue":"11","key":"2019111807070775800_B45","doi-asserted-by":"crossref","first-page":"e8055","DOI":"10.1371\/journal.pone.0008055","article-title":"PPARgamma regulates trophoblast proliferation and promotes labyrinthine trilineage differentiation.","volume":"4","author":"Parast","year":"2009","journal-title":"PLoS One"},{"issue":"6771","key":"2019111807070775800_B46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/35001608","article-title":"Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis.","volume":"403","author":"Mi","year":"2000","journal-title":"Nature"},{"issue":"8","key":"2019111807070775800_B47","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2005-10-4111","article-title":"Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells.","volume":"107","author":"Sood","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111807070775800_B48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0038-1642773","article-title":"Factor VIII procoagulant antigen in human tissues.","volume":"59","author":"Kadhom","year":"1988","journal-title":"Thromb Haemost"},{"issue":"12","key":"2019111807070775800_B49","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.ATV.0000042456.84190.F0","article-title":"Characterization of the association of tissue factor pathway inhibitor with human placenta.","volume":"22","author":"Mast","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2019111807070775800_B50","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1073\/pnas.91.8.3353","article-title":"Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.","volume":"91","author":"Sprecher","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111807070775800_B51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1055\/s-0038-1661459","article-title":"Coextraction of thrombomodulin and tissue factor from human placenta: effects of concanavalin A and phospholipid environment on activity.","volume":"55","author":"Freyssinet","year":"1986","journal-title":"Thromb Haemost"},{"issue":"19","key":"2019111807070775800_B52","doi-asserted-by":"crossref","first-page":"12246","DOI":"10.1016\/S0021-9258(20)71346-3","article-title":"Isolation and characterization of thrombomodulin from human placenta.","volume":"259","author":"Salem","year":"1984","journal-title":"J Biol Chem"},{"issue":"6","key":"2019111807070775800_B53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0143-4004(05)80407-2","article-title":"The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation.","volume":"15","author":"Krikun","year":"1994","journal-title":"Placenta"},{"issue":"9741","key":"2019111807070775800_B54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","article-title":"Pre-eclampsia.","volume":"376","author":"Steegers","year":"2010","journal-title":"Lancet"},{"key":"2019111807070775800_B55","doi-asserted-by":"crossref","first-page":"d1875","DOI":"10.1136\/bmj.d1875","article-title":"Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort.","volume":"342","author":"North","year":"2011","journal-title":"BMJ"},{"issue":"5728","key":"2019111807070775800_B56","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia.","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"issue":"4","key":"2019111807070775800_B57","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent.","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2019111807070775800_B58","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2007.09.031","article-title":"Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images.","volume":"198","author":"Toal","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2019111807070775800_B59","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/AOG.0b013e31820ca040","article-title":"Placental infarction and thrombophilia.","volume":"117","author":"Franco","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"9694","key":"2019111807070775800_B60","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.","volume":"374","author":"Koopmans","year":"2009","journal-title":"Lancet"},{"issue":"9761","key":"2019111807070775800_B61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.","volume":"377","author":"von Dadelszen","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"2019111807070775800_B62","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ajog.2004.12.014","article-title":"An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women.","volume":"193","author":"Yu","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2019111807070775800_B63","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1701-2163(16)32756-6","article-title":"Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.","volume":"30","author":"Toal","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"issue":"9","key":"2019111807070775800_B64","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1471-0528.2011.02951.x","article-title":"Early-pregnancy changes in cardiac diastolic function in women with recurrent pre-eclampsia and in previously pre-eclamptic women without recurrent disease.","volume":"118","author":"Sep","year":"2011","journal-title":"BJOG"},{"issue":"7","key":"2019111807070775800_B65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia.","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"issue":"24","key":"2019111807070775800_B66","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","article-title":"Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.","volume":"123","author":"Powe","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"2019111807070775800_B67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.109.141473","article-title":"Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats.","volume":"55","author":"Murphy","year":"2010","journal-title":"Hypertension"},{"issue":"6B","key":"2019111807070775800_B68","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1582-4934.2009.00820.x","article-title":"Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model.","volume":"14","author":"Bergmann","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"6","key":"2019111807070775800_B69","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"9","key":"2019111807070775800_B70","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCRESAHA.110.239665","article-title":"Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase.","volume":"108","author":"Sela","year":"2011","journal-title":"Circ Res"},{"issue":"7114","key":"2019111807070775800_B71","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1.","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"2019111807070775800_B72","article-title":"Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin [published online ahead of print May 7, 2011].","author":"Carroll","journal-title":"Am J Reprod Immunol"},{"key":"2019111807070775800_B73","article-title":"Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling [published online ahead of print October 10, 2011].","author":"Drewlo","journal-title":"J Thromb Hemost"},{"issue":"8","key":"2019111807070775800_B74","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/labinvest.3780326","article-title":"Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women.","volume":"81","author":"Reister","year":"2001","journal-title":"Lab Invest"},{"issue":"5-6","key":"2019111807070775800_B75","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/plac.1999.0395","article-title":"Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction.","volume":"20","author":"Ferrazzi","year":"1999","journal-title":"Placenta"},{"issue":"7","key":"2019111807070775800_B76","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2005-0078","article-title":"Molecular evidence of placental hypoxia in preeclampsia.","volume":"90","author":"Soleymanlou","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019111807070775800_B77","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.RES.0000024411.22110.AA","article-title":"Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia.","volume":"90","author":"Hung","year":"2002","journal-title":"Circ Res"},{"issue":"2","key":"2019111807070775800_B78","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/HYPERTENSIONAHA.111.172627","article-title":"Peroxisome proliferator-activated receptor-{gamma} as a potential therapeutic target in the treatment of preeclampsia.","volume":"58","author":"McCarthy","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"2019111807070775800_B79","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.placenta.2003.10.014","article-title":"Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia.","volume":"25","author":"Chen","year":"2004","journal-title":"Placenta"},{"key":"2019111807070775800_B80","article-title":"Reduced expression of both Syncytin 1 and Syncytin 2 correlates with severity of preeclampsia [published online ahead of print April 14, 2011].","author":"Vargas","journal-title":"Reprod Sci"},{"issue":"1","key":"2019111807070775800_B81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000209396","article-title":"Syncytin-1 and glial cells missing a: hypoxia-induced deregulated gene expression along with disordered cell fusion in primary term human trophoblasts.","volume":"68","author":"Wich","year":"2009","journal-title":"Gynecol Obstet Invest"},{"issue":"26","key":"2019111807070775800_B82","doi-asserted-by":"crossref","first-page":"17411","DOI":"10.1074\/jbc.M109.016170","article-title":"Mechanism of hypoxia-induced GCM1 degradation: implications for the pathogenesis of preeclampsia.","volume":"284","author":"Chiang","year":"2009","journal-title":"J Biol Chem"},{"issue":"4","key":"2019111807070775800_B83","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.placenta.2011.01.018","article-title":"Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A.","volume":"32","author":"Fitzgerald","year":"2011","journal-title":"Placenta"},{"issue":"2-3","key":"2019111807070775800_B84","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/plac.2002.0903","article-title":"Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation.","volume":"24","author":"Huppertz","year":"2003","journal-title":"Placenta"},{"issue":"9","key":"2019111807070775800_B85","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.humpath.2010.11.018","article-title":"Placental expression of vascular endothelial growth factor receptor-1\/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity.","volume":"42","author":"Tache","year":"2011","journal-title":"Hum Pathol"},{"issue":"4","key":"2019111807070775800_B86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/JPM.2009.060","article-title":"Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.","volume":"37","author":"Teng","year":"2009","journal-title":"J Perinat Med"},{"key":"2019111807070775800_B87","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S0049-3848(11)70019-6","article-title":"Microparticles and pregnancy complications.","volume":"127","author":"Aharon","year":"2011","journal-title":"Thromb Res"},{"issue":"6","key":"2019111807070775800_B88","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1471-0528.1998.tb10178.x","article-title":"Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies.","volume":"105","author":"Knight","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"4","key":"2019111807070775800_B89","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1538-7836.2007.02427.x","article-title":"The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials.","volume":"5","author":"Lazo-Langner","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2019111807070775800_B90","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.thromres.2007.06.015","article-title":"Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.","volume":"121","author":"Marchetti","year":"2008","journal-title":"Thromb Res"},{"issue":"11","key":"2019111807070775800_B91","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/01.ATV.0000090671.56682.D7","article-title":"Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.","volume":"23","author":"Khorana","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5396","key":"2019111807070775800_B92","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1126\/science.282.5396.2072","article-title":"Promotion of trophoblast stem cell proliferation by FGF4.","volume":"282","author":"Tanaka","year":"1998","journal-title":"Science"},{"issue":"1","key":"2019111807070775800_B93","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ydbio.2004.03.029","article-title":"The Hand1, Stra13 and Gcm1 transcription factors override FGF signaling to promote terminal differentiation of trophoblast stem cells.","volume":"271","author":"Hughes","year":"2004","journal-title":"Dev Biol"},{"issue":"4-5","key":"2019111807070775800_B94","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.placenta.2005.03.006","article-title":"Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi.","volume":"27","author":"Baczyk","year":"2006","journal-title":"Placenta"},{"issue":"4","key":"2019111807070775800_B95","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/molehr\/gal026","article-title":"Heparin prevents programmed cell death in human trophoblast.","volume":"12","author":"Hills","year":"2006","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"2019111807070775800_B96","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ajog.2004.05.014","article-title":"Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro.","volume":"191","author":"Bose","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2019111807070775800_B97","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/AOG.0b013e31821b5384","article-title":"angiogenic response of placental villi to heparin.","volume":"117","author":"Sobel","year":"2011","journal-title":"Obst Gynecol"},{"issue":"5","key":"2019111807070775800_B98","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/HYPERTENSIONAHA.111.169755","article-title":"Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension.","volume":"57","author":"George","year":"2011","journal-title":"Hypertension"},{"issue":"4","key":"2019111807070775800_B99","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1471-0528.2009.02473.x","article-title":"The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.","volume":"117","author":"Lynch","year":"2010","journal-title":"BJOG"},{"issue":"3","key":"2019111807070775800_B100","doi-asserted-by":"crossref","first-page":"e1001013","DOI":"10.1371\/journal.pmed.1001013","article-title":"Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort.","volume":"8","author":"Salmon","year":"2011","journal-title":"PLoS Med"},{"issue":"11","key":"2019111807070775800_B101","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"2019111807070775800_B102","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.302.1.290","article-title":"Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration.","volume":"302","author":"Christopherson","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"2019111807070775800_B103","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/OGX.0b013e3182227027","article-title":"Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review.","volume":"66","author":"Kuc","year":"2011","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"2019111807070775800_B104","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/AOG.0b013e3181da93da","article-title":"First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes.","volume":"115","author":"Dugoff","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"8-9","key":"2019111807070775800_B105","first-page":"A41","article-title":"Role of placental ultrasound to predict adverse pregnancy outcomes in women with low PAPP-A at 11-13 weeks.","volume":"28","author":"Proctor","year":"2007","journal-title":"Placenta"},{"issue":"4","key":"2019111807070775800_B106","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajog.2006.10.897","article-title":"Usefulness of a placental profile in high-risk pregnancies.","volume":"196","author":"Toal","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2019111807070775800_B107","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1538-7836.2011.04407.x","article-title":"Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial.","volume":"9","author":"Kingdom","year":"2011","journal-title":"J Thromb Haemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/18\/4780\/1463965\/zh804411004780.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/18\/4780\/1463965\/zh804411004780.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:05:23Z","timestamp":1638403523000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/18\/4780\/29343\/Is-heparin-a-placental-anticoagulant-in-highrisk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":107,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011,11,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-07-319749","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}